Klinge L, de Muckadell O B
Odense Universitetshospital, medicinsk gastroenterologisk afdeling S.
Ugeskr Laeger. 2001 Aug 20;163(34):4571-3.
This review should be cited as: De Bruyn G, Hahn S, Borwick A. Antibiotic treatment for travellers' diarrhoea (Cochrane Review). In: The Cochrane Library, Issue 1, 2001. Oxford: Update Software. A substantive amendment to this systematic review was last made on 21 May 2000. Cochrane reviews are regularly checked and updated if necessary.
Traveller's diarrhoea is a syndrome frequently encountered in persons crossing an international boundary. Diarrhoea can lead to significant discomfort and interference with travel plans. Bacterial pathogens are a frequent course of this syndrome. Several antibiotics have been tested for efficacy in reducing the duration and severity of the illness.
The aims of the review were to access the effects of antibiotics on traveller's diarrhoea in relation to the duration of illness, severity of illness, and adverse effects of medications.
The Cochrane Collaboration Trials Register, MEDLINE, and EMBASE were searched. Additional trials were identified by hand searching. Content experts were contacted.
All trials in any language in which travellers older than five years were randomly allocated to treatment for acute non-bloody diarrhoea with antibiotics and where the causative organism is not known at allocation.
Two reviewers assessed trial quality and extracted data.
Twenty published studies met inclusion and quality criteria for inclusion. Twelve studies were placebo-controlled. A meta-analysis for the primary outcome was not feasible. All of the ten trials reported a significant reduction in duration of diarrhoea in participants treated with antibiotics compared with placebo. Data from two trials demonstrated a small reduction for antibiotic treated patients in the number of unformed stools passed per each 24 hour period from randomisation up to 72 hours. Data from six trials demonstrated a greater number of participants being cured of diarrhoea by 72 hours (odds ratio [OR] 5.9, 95% confidence interval [CI] 4.06 to 8.57). Data regarding side effects were available from five trials. There was wide variation in the prevalence of side effects reported in different trials. Persons taking antibiotics experienced more side effects than those taking placebo (OR 2.37, 95% CI 1.5 to 3.75). REVIEWERS' CONCLUSION: Antibiotic treatment is associated with shorter duration of diarrhoea but higher incidence of side effects. Trials generally do not report duration of post-treatment diarrhoea using time-to-event analyses, and should do.
本综述应引用为:德布鲁因 G、哈恩 S、博里克 A。旅行者腹泻的抗生素治疗(Cochrane 综述)。载于《Cochrane 图书馆》,2001 年第 1 期。牛津:更新软件公司。本系统综述的实质性修订于 2000 年 5 月 21 日最后完成。Cochrane 综述会定期检查并在必要时更新。
旅行者腹泻是跨境旅行者中常见的一种综合征。腹泻会导致严重不适并干扰旅行计划。细菌病原体是该综合征的常见病因。已经对几种抗生素在缩短疾病持续时间和减轻严重程度方面的疗效进行了测试。
本综述的目的是评估抗生素对旅行者腹泻在疾病持续时间、疾病严重程度和药物不良反应方面的影响。
检索了 Cochrane 协作网试验注册库、MEDLINE 和 EMBASE。通过手工检索确定了其他试验。联系了内容专家。
所有语言的试验,其中五岁以上的旅行者被随机分配接受抗生素治疗急性非血性腹泻,且在分配时病原体未知。
两名综述作者评估试验质量并提取数据。
20 项已发表的研究符合纳入标准和质量标准。12 项研究为安慰剂对照。对主要结局进行荟萃分析不可行。所有 10 项试验均报告,与安慰剂相比,接受抗生素治疗的参与者腹泻持续时间显著缩短。两项试验的数据表明,从随机分组到 72 小时,接受抗生素治疗的患者每 24 小时排出不成形粪便的数量略有减少。六项试验的数据表明,到 72 小时时有更多参与者腹泻治愈(优势比[OR]5.9,95%置信区间[CI]4.06 至 8.57)。五项试验提供了关于副作用的数据。不同试验报告的副作用发生率差异很大。服用抗生素的人比服用安慰剂的人经历更多副作用(OR 2.37,95%CI 1.5 至 3.75)。综述作者结论:抗生素治疗与腹泻持续时间缩短相关,但副作用发生率较高。试验通常未使用事件发生时间分析报告治疗后腹泻的持续时间,应该这样做。